Skip to main content
. 2017 Jul 19;7:5814. doi: 10.1038/s41598-017-06261-5

Figure 6.

Figure 6

POL improved HBV specific liver pathological conditions in HBV -transgenic mice. (A) 7 days after the 3rd treatment, the serum of HBV -transgenic mice were collected for HBV surface antibody level by using HBV surface antibody kit. (B) 7 days after the 3rd treatment, the serum of HBV -transgenic mice were collected for HBV surface antigen level by using HBV surface antigen kit. (C) 7 days after the 3rd treatment, the livers of treated mice were prepared for pathological sections by HE staining. (D) 7 days after the 3rd treatment, the livers of treated mice were prepared for HBVsAg expression by immunohistochemistry staining. Shown in each panel is 1 of at least 3 experiments with similar results. Bar, mean and SD from 3 independent experiments, each using at least three mice per group (n = 3); *p < 0.05; **p < 0.01.